Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers.
BACKGROUND
To explore the influence of ovarian cancer histotype on the effectiveness of adjuvant radiotherapy (RT).


METHODS
A review of a population-based experience included all referred women with no reported macroscopic residuum following primary surgery who underwent adjuvant platin-based chemotherapy (CT), with or without sequential RT, and for whom it was possible to assign histotype according to the contemporary criteria.


RESULTS
Seven hundred and three subjects were eligible, of these 351 received RT. For those with apparent stage I and II tumors, the cohort with clear cell (C), endometrioid (E), and mucinous (M) disease who additionally received RT exhibited a 40% reduction in disease-specific mortality and a 43% reduction in overall mortality.


CONCLUSIONS
The curability of those with stage I and II C-, E-, and M-type ovarian carcinomas was enhanced by RT-containing adjuvant therapy. This benefit did not extend to those with stage III or serous tumors. These findings necessitate reassessments of the role of RT and of the nonselective surgical and CT approaches that have characterized ovarian cancer care.
Swenerton
K D
KD
The Gynecology Tumour Group. kswener@bccancer.bc.ca
Santos
J L
JL
Gilks
C B
CB
Köbel
M
M
Hoskins
P J
PJ
Wong
F
F
Le
N D
ND
D000368:Aged; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D016019:Survival Analysis